Gauting, Germany

Elisabeth Thomassen-Wolf

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • München, DE (2009)
  • Gauting, DE (2011 - 2021)

Company Filing History:


Years Active: 2009-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Elisabeth Thomassen-Wolf: Pioneering Innovator in Biomedical Solutions

Introduction:

Elisabeth Thomassen-Wolf, a trailblazing inventor based in Gauting, Germany, has garnered recognition for her exceptional dedication to developing impactful solutions through innovation. Her impressive portfolio of patents reveals her significant contributions to the field of biomedicine, particularly in addressing inflammatory diseases such as rheumatoid arthritis.

Latest Patents:

Elisabeth Thomassen-Wolf's recent patents include groundbreaking inventions in the field of biomedicine. One notable patent covers nucleic acid sequences encoding anti-GM-CSF antibodies. These antibodies target GM-CSF, a key player in various disorders, offering a promising avenue for treating inflammatory conditions. Additionally, her patent encompasses methods of treatment utilizing these antibodies, showcasing her commitment to advancing therapeutic approaches in healthcare.

Career Highlights:

Throughout her career, Elisabeth Thomassen-Wolf has demonstrated unwavering dedication to driving innovation in biomedicine. Her work at renowned companies like Morphosys AG and GPC Biotech, Inc. has been instrumental in shaping cutting-edge solutions for complex medical challenges. By leveraging her expertise in antibody research, she has made significant strides in developing novel treatments that have the potential to transform patient care.

Collaborations:

Elisabeth Thomassen-Wolf has collaborated with esteemed professionals in the biomedical field, including accomplished colleagues such as Stefan Steidl and Zoltan Nagy. Together, they have synergized their expertise to further the development of innovative solutions for combating inflammatory diseases and advancing the understanding of GM-CSF's role in various disorders. These collaborations have not only enriched her work but have also fostered a collaborative spirit within the scientific community.

Conclusion:

In conclusion, Elisabeth Thomassen-Wolf's pioneering spirit and relentless pursuit of excellence have positioned her as a visionary inventor in the realm of biomedicine. Her inventive solutions and dedication to advancing healthcare have left an indelible mark on the field, inspiring future generations of inventors to push the boundaries of innovation. As she continues to innovate and create impactful solutions, Elisabeth Thomassen-Wolf sets a shining example of what is possible through passion, dedication, and ingenuity in the world of inventing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…